ข่าวประชาสัมพันธ์ Intellect Neurosciences+the company

Duck Creek Technologies Appoints General Daniel Hokanson, USA, Ret. to Board of Directors

Duck Creek Technologies Decorated general brings extensive leadership and policy development expertise to board role Duck Creek Technologies , the global intelligent solutions provider defining the future of property and casualty (P&C) and general insurance, has announced the appointment of General Daniel Hokanson, USA, Ret. to the company's board of directors. He brings deep expertise and experience in leading organizations through the development and implementation of detailed strategic policy

KTC has been upgraded to an "AA" corporat... KTC Delighted with New "AA" Rating from TRIS, Strengthening Its Path Toward Sustainable Growth — KTC has been upgraded to an "AA" corporate and debt ratin...

Kaspersky has launched a major update to ... Kaspersky Research Sandbox 3.0: more power, less hardware — Kaspersky has launched a major update to Kaspersky Research Sandbox, introducing version 3.0 w...

Electricity Generating Public Company Lim... EGCO Group boosts its renewables fleet with acquisition of 251 MW wind and solar farms in the US — Electricity Generating Public Company Limited or EGCO G...

The upgrade reflects CKPower's strengthen... CKPower's Debenture Credit Rating Upgraded to "A-" from "BBB+" by TRIS Rating — The upgrade reflects CKPower's strengthened debt structure, enhanced finan...

Thaioil and Krungthai Bank have signed a ... Thaioil and Krungthai Sign MOU on ESG-Linked FX Hedging to Drive Sustainable Organization — Thaioil and Krungthai Bank have signed a Memorandum of Underst...

Exotic Food Public Company Limited commit... Exotic Food Launches Climate Change Management Project - Transition to Net Zero 2050 — Exotic Food Public Company Limited commits to sustainable developme...

Bitkub Capital Group Holdings Co., Ltd., ... Bitkub wins top leadership and workplace awards — Bitkub Capital Group Holdings Co., Ltd., a leading Thai company in digital assets and blockchain te...

Fitch Affirms Thailand's Land and Houses Securities at 'AA(tha)': Outlook Stable

Fitch Ratings (Thailand) has affirmed Land and Houses Securities Public Company Limited's (LHS) National Long-Term Rating at 'AA(tha)' and National Short-Term Rating at 'F1+(tha)'. The Outlook is Stable. Key Rating...

Rossini's Invites You to Indulge in Delig... Rossini's Invites You to Indulge in Delightfully Relaxing Dining with Italy's "Aperitivo" — Rossini's Invites You to Indulge in Delightfully Relaxing Dini...

SIG Thailand has been awarded three key c... SIG receives recognition for lowering carbon footprint across packaging and operations in Thailand — SIG Thailand has been awarded three key carbon reduct...

Following the lean months of winter, East... Easter Feasts at InterContinental Bangkok — Following the lean months of winter, Easter is a time for regeneration and strength-building for the balmy...

Intellect Neurosciences, Inc. เตรียมเสนอผลงานในการประชุม BIO Asia International Conference

Intellect Neurosciences, Inc. (OTCPK: ILNS) ประกาศว่า ดร.แดเนียล จี. เชน (Dr. Daniel G. Chain) ประธานและซีอีโอของบริษัท จะเข้าร่วมการประชุม BIO Asia International Conference ประจำปีครั้งที่ 9...

Intellect Neurosciences, Inc. to Present at BIO Asia International Conference

Intellect Neurosciences, Inc. (OTCPK: ILNS) announces that Dr. Daniel G. Chain, chairman and CEO will be presenting at the 9th Annual BIO Asia International Conference. The meeting will take place January 31 –February 1 at...

Intellect Neurosciences ได้รับสิทธิบัตรใหม่ 2 ใบในญี่ปุ่น สำหรับเทคโนโลยีภูมิคุ้มกันบำบัดโรคอัลไซเมอร์

Intellect Neurosciences, Inc. (OTCBB: ILNS) บริษัทชีวเวชภัณฑ์ซึ่งทุ่มเทให้กับการคิดค้นและพัฒนายาปรับสภาพของโรค สำหรับรักษาโรคอัลไซเมอร์และโรคระบบประสาทอื่นๆ ประกาศว่า สำนักงานสิทธิบัตรญี่ปุ่น ...

Intellect Neurosciences Obtains Two New Patents in Japan for Its Alzheimer's Immunotherapy Programs

Intellect Neurosciences, Inc. (OTCBB: ILNS), a biopharmaceutical company engaged in the discovery and development of disease-modifying therapeutic agents for the treatment of Alzheimer's and other...